Belite Bio (BLTE) Interest Expenses (2021 - 2025)

Belite Bio's Interest Expenses history runs 5 years deep, the most recent figure standing at $359.7 million for Q4 2025.

• On a quarterly basis, Interest Expenses rose 58960.92% year-over-year to $359.7 million in Q4 2025; TTM through Dec 2025 was $359.7 million, a 58960.92% increase from a year earlier, with the FY2025 full-year figure at $359.7 million, up 31.58% from the prior year.
• Interest Expenses climbed to $359.7 million in Q4 2025 per BLTE's latest filing, from $609000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $359.7 million in Q4 2025 and bottomed at $347000.0 in Q4 2023.
• The 5-year median for Interest Expenses is $4.5 million (2021), against an average of $75.1 million.
• Across the five-year window, Interest Expenses sank 96.69% in 2023 and soared 58960.92% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $4.5 million in 2021, then jumped by 133.77% to $10.5 million in 2022, then sank by 96.69% to $347000.0 in 2023, then surged by 75.5% to $609000.0 in 2024, then surged by 58960.92% to $359.7 million in 2025.
• Per Business Quant, the three latest BLTE Interest Expenses figures stand at $359.7 million (Q4 2025), $609000.0 (Q4 2024), and $347000.0 (Q4 2023).